Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dimethylhydrazine | decreases expression | ISO | Tubgcp3 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of TUBGCP3 mRNA | CTD | PMID:22206623 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | TUBGCP3 (Homo sapiens) | 6480464 | Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of TUBGCP3 mRNA] | CTD | PMID:11007951 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | TUBGCP3 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin affects the expression of TUBGCP3 mRNA | CTD | PMID:22574217 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Tubgcp3 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of TUBGCP3 mRNA | CTD | PMID:19465110 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | TUBGCP3 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of TUBGCP3 mRNA | CTD | PMID:11007951 | 2-palmitoylglycerol | increases expression | ISO | TUBGCP3 (Homo sapiens) | 6480464 | 2-palmitoylglycerol results in increased expression of TUBGCP3 mRNA | CTD | PMID:37199045 | 4,4'-sulfonyldiphenol | decreases expression | ISO | Tubgcp3 (Mus musculus) | 6480464 | bisphenol S results in decreased expression of TUBGCP3 mRNA | CTD | PMID:33297965 | aflatoxin B1 | decreases methylation | ISO | TUBGCP3 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of TUBGCP3 polyA tail | CTD | PMID:30157460 | Aflatoxin B2 alpha | decreases methylation | ISO | TUBGCP3 (Homo sapiens) | 6480464 | aflatoxin B2 results in decreased methylation of TUBGCP3 polyA tail | CTD | PMID:30157460 | aristolochic acid A | decreases expression | ISO | TUBGCP3 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of TUBGCP3 mRNA | CTD | PMID:33212167 | arsane | affects methylation | ISO | TUBGCP3 (Homo sapiens) | 6480464 | Arsenic affects the methylation of TUBGCP3 gene | CTD | PMID:25304211 | arsenic atom | affects methylation | ISO | TUBGCP3 (Homo sapiens) | 6480464 | Arsenic affects the methylation of TUBGCP3 gene | CTD | PMID:25304211 | arsenite(3-) | multiple interactions | ISO | TUBGCP3 (Homo sapiens) | 6480464 | arsenite inhibits the reaction [G3BP1 protein binds to TUBGCP3 mRNA] | CTD | PMID:32406909 | avobenzone | increases expression | ISO | TUBGCP3 (Homo sapiens) | 6480464 | avobenzone results in increased expression of TUBGCP3 mRNA | CTD | PMID:31016361 | benzo[a]pyrene | decreases expression | ISO | TUBGCP3 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of TUBGCP3 mRNA | CTD | PMID:20064835 | benzo[a]pyrene | affects methylation | ISO | TUBGCP3 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of TUBGCP3 polyA tail | CTD | PMID:30157460 | benzo[a]pyrene diol epoxide I | decreases expression | ISO | TUBGCP3 (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:19150397 and PMID:20382639 | benzo[e]pyrene | decreases methylation | ISO | TUBGCP3 (Homo sapiens) | 6480464 | benzo(e)pyrene results in decreased methylation of TUBGCP3 polyA tail | CTD | PMID:30157460 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of TUBGCP3 mRNA | CTD | PMID:25181051 and PMID:30816183 | bisphenol A | multiple interactions | ISO | TUBGCP3 (Homo sapiens) | 6480464 | [[ginger extract results in increased abundance of Oils and Volatile] which co-treated with bisphenol A] affects the expression of TUBGCP3 protein | CTD | PMID:33376534 | bisphenol A | decreases expression | ISO | Tubgcp3 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of TUBGCP3 mRNA | CTD | PMID:33221593 | CGP 52608 | multiple interactions | ISO | TUBGCP3 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to TUBGCP3 gene] | CTD | PMID:28238834 | chlorpyrifos | decreases expression | ISO | Tubgcp3 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of TUBGCP3 mRNA | CTD | PMID:37019170 | choline | multiple interactions | ISO | Tubgcp3 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of TUBGCP3 gene | CTD | PMID:20938992 | clothianidin | increases expression | ISO | TUBGCP3 (Homo sapiens) | 6480464 | clothianidin results in increased expression of TUBGCP3 mRNA | CTD | PMID:31626844 | cycloheximide | multiple interactions | ISO | TUBGCP3 (Homo sapiens) | 6480464 | Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of TUBGCP3 mRNA] | CTD | PMID:11007951 | cyclosporin A | increases expression | ISO | Tubgcp3 (Mus musculus) | 6480464 | Cyclosporine results in increased expression of TUBGCP3 mRNA | CTD | PMID:19770486 | cyclosporin A | increases expression | ISO | TUBGCP3 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of TUBGCP3 mRNA | CTD | PMID:27989131 | dimethylarsinous acid | increases expression | ISO | TUBGCP3 (Homo sapiens) | 6480464 | dimethylarsinous acid results in increased expression of TUBGCP3 mRNA | CTD | PMID:23487506 | dorsomorphin | multiple interactions | ISO | TUBGCP3 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | ethanol | affects splicing | ISO | Tubgcp3 (Mus musculus) | 6480464 | Ethanol affects the splicing of TUBGCP3 mRNA | CTD | PMID:30319688 | flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of TUBGCP3 mRNA | CTD | PMID:20566332 | folic acid | multiple interactions | ISO | Tubgcp3 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of TUBGCP3 gene | CTD | PMID:20938992 | folic acid | decreases expression | ISO | Tubgcp3 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of TUBGCP3 mRNA | CTD | PMID:25629700 | furan | increases methylation | EXP | | 6480464 | furan results in increased methylation of TUBGCP3 gene | CTD | PMID:22079235 | indometacin | decreases expression | ISO | TUBGCP3 (Homo sapiens) | 6480464 | Indomethacin results in decreased expression of TUBGCP3 mRNA | CTD | PMID:16984733 | ivermectin | decreases expression | ISO | TUBGCP3 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of TUBGCP3 protein | CTD | PMID:32959892 | L-methionine | multiple interactions | ISO | Tubgcp3 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of TUBGCP3 gene | CTD | PMID:20938992 | lead(0) | increases expression | ISO | TUBGCP3 (Homo sapiens) | 6480464 | Lead results in increased expression of TUBGCP3 mRNA | CTD | PMID:19921347 | methapyrilene | decreases methylation | ISO | TUBGCP3 (Homo sapiens) | 6480464 | Methapyrilene results in decreased methylation of TUBGCP3 polyA tail | CTD | PMID:30157460 | methoxychlor | affects methylation | EXP | | 6480464 | Methoxychlor affects the methylation of TUBGCP3 gene | CTD | PMID:35440735 | methylmercury chloride | decreases expression | ISO | TUBGCP3 (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of TUBGCP3 mRNA | CTD | PMID:28001369 | N-acetyl-beta-D-glucosamine | decreases expression | ISO | TUBGCP3 (Homo sapiens) | 6480464 | Acetylglucosamine results in decreased expression of TUBGCP3 mRNA | CTD | PMID:18047607 | N-acetyl-D-glucosamine | decreases expression | ISO | TUBGCP3 (Homo sapiens) | 6480464 | Acetylglucosamine results in decreased expression of TUBGCP3 mRNA | CTD | PMID:18047607 | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of TUBGCP3 mRNA | CTD | PMID:25729387 | paracetamol | decreases expression | ISO | TUBGCP3 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of TUBGCP3 mRNA | CTD | PMID:21420995 | phenylmercury acetate | decreases expression | ISO | TUBGCP3 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in decreased expression of TUBGCP3 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | ISO | TUBGCP3 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TUBGCP3 mRNA | CTD | PMID:27188386 | quercetin | decreases expression | ISO | TUBGCP3 (Homo sapiens) | 6480464 | Quercetin results in decreased expression of TUBGCP3 mRNA | CTD | PMID:21632981 | resveratrol | multiple interactions | ISO | TUBGCP3 (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of TUBGCP3 mRNA | CTD | PMID:23557933 | rotenone | affects expression | ISO | Tubgcp3 (Mus musculus) | 6480464 | Rotenone affects the expression of TUBGCP3 mRNA | CTD | PMID:21893155 | rotenone | multiple interactions | ISO | Tubgcp3 (Mus musculus) | 6480464 | TRP53 affects the reaction [Rotenone affects the expression of TUBGCP3 mRNA] | CTD | PMID:21893155 | SB 431542 | multiple interactions | ISO | TUBGCP3 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | sunitinib | increases expression | ISO | TUBGCP3 (Homo sapiens) | 6480464 | Sunitinib results in increased expression of TUBGCP3 mRNA | CTD | PMID:31533062 | tert-butyl hydroperoxide | decreases expression | ISO | TUBGCP3 (Homo sapiens) | 6480464 | tert-Butylhydroperoxide results in decreased expression of TUBGCP3 mRNA | CTD | PMID:15336504 | tetraphene | increases expression | ISO | Tubgcp3 (Mus musculus) | 6480464 | benz(a)anthracene results in increased expression of TUBGCP3 mRNA | CTD | PMID:26377693 | thimerosal | increases expression | ISO | TUBGCP3 (Homo sapiens) | 6480464 | Thimerosal results in increased expression of TUBGCP3 mRNA | CTD | PMID:27188386 | titanium dioxide | increases expression | ISO | Tubgcp3 (Mus musculus) | 6480464 | titanium dioxide results in increased expression of TUBGCP3 mRNA | CTD | PMID:29264374 | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of TUBGCP3 mRNA | CTD | PMID:25729387 | topotecan | affects response to substance | ISO | TUBGCP3 (Homo sapiens) | 6480464 | TUBGCP3 protein affects the susceptibility to Topotecan | CTD | PMID:16217747 | tributylstannane | decreases expression | EXP | | 6480464 | tributyltin results in decreased expression of TUBGCP3 mRNA | CTD | PMID:31129395 | trichostatin A | affects expression | ISO | TUBGCP3 (Homo sapiens) | 6480464 | trichostatin A affects the expression of TUBGCP3 mRNA | CTD | PMID:28542535 | urethane | decreases expression | ISO | TUBGCP3 (Homo sapiens) | 6480464 | Urethane results in decreased expression of TUBGCP3 mRNA | CTD | PMID:28818685 | valproic acid | decreases expression | ISO | TUBGCP3 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of TUBGCP3 mRNA | CTD | PMID:26272509 | valproic acid | multiple interactions | ISO | TUBGCP3 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TUBGCP3 mRNA | CTD | PMID:27188386 | |